Novem Group »

Halozyme Therapeutics shares owned by Novem Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Novem Group from 13F filings

Historical chart of Novem Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Novem Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Novem Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $210k 2.9k 73.34
2025-03-31 $1.4M 22k 63.81
2024-12-31 $841k 18k 47.81